These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 6928602

  • 21. [Immunology and immunotherapy of leukemia (basic results of 8-years research)].
    Bergol'ts VM.
    Vopr Onkol; 1978; 24(11):16-24. PubMed ID: 283626
    [Abstract] [Full Text] [Related]

  • 22. [Results of 3 protocols of treatment of acute lymphoid leukemia in children].
    Mathé G, de Vassal F, Schwarzenberg L, Delgado M, Weiner R, Gil MA, Pena-Angulo J, Belpomme D, Pouillart P, Machover D, Misset JL, Pico JL, Jasmin C, Hayat M, Schneider M, Cattan A, Amiel JL, Musset M, Rosenfeld C, Ribaud P.
    Arch Fr Pediatr; 1977; 34(7):611-21. PubMed ID: 270966
    [No Abstract] [Full Text] [Related]

  • 23. Five-year follow-up of immunotherapy in acute lymphoblastic leukaemia.
    Baker MA, Taub RN.
    Lancet; 1977 Jun 18; 1(8025):1308-9. PubMed ID: 68403
    [No Abstract] [Full Text] [Related]

  • 24. [Immunotherapy of leukemia--a realistic clinical possibility?].
    Gahrton G.
    Lakartidningen; 1971 Mar 31; 68(14):1601-8. PubMed ID: 4930453
    [No Abstract] [Full Text] [Related]

  • 25. BCG as active immunotherapy in children with acute lymphoblastic leukemia in longstanding remission: positive effects on remission duration and immunologic parameters.
    Miale TD, Yocum D, Yocum C.
    Biomedicine; 1978 May 31; 28(2):96-104. PubMed ID: 276382
    [Abstract] [Full Text] [Related]

  • 26. [Current treatment of acute leukemias].
    Sans-Sabrafen J.
    Med Clin (Barc); 1981 Mar 25; 76(6):275-8. PubMed ID: 7019595
    [No Abstract] [Full Text] [Related]

  • 27. Immunotherapy for malignant disease.
    Med Lett Drugs Ther; 1976 Sep 24; 18(20):83-4. PubMed ID: 1066519
    [No Abstract] [Full Text] [Related]

  • 28. Critical review of previously reported clinical trials of cancer immunotherapy with nonspecific immunostimulants.
    Mastrangelo MJ, Berd D, Bellet RE.
    Ann N Y Acad Sci; 1976 Sep 24; 277(00):94-123. PubMed ID: 793490
    [No Abstract] [Full Text] [Related]

  • 29. [BCG, or immunotherapy of hope].
    Monti A.
    Minerva Med; 1975 Oct 24; 66(68 Suppl):7-9. PubMed ID: 1059000
    [No Abstract] [Full Text] [Related]

  • 30. The place of immunological methods of treatment in the management of acute leukaemia.
    Powles RL, Russell JA.
    Hamatol Bluttransfus; 1976 Oct 24; 19():297-304. PubMed ID: 795744
    [No Abstract] [Full Text] [Related]

  • 31. Immunotherapy in acute leukemias. Possible applications in children.
    Mahoney DH, Starling KA.
    Am J Pediatr Hematol Oncol; 1981 Oct 24; 3(4):410-8. PubMed ID: 7036781
    [Abstract] [Full Text] [Related]

  • 32. Immunotherapy for acute myelogenous leukemia using irradiated and unirradiated leukemia cells.
    Powles R.
    Cancer; 1974 Oct 24; 34(4 Suppl):suppl:1558-62. PubMed ID: 4608692
    [No Abstract] [Full Text] [Related]

  • 33. Immune complexes in children with leukemia: relationship to disease characteristics and to antibody response to Mycobacterium bovis (BCG) in patients receiving BCG immunotherapy.
    Minden P, Odom LF, Tubergen DG, Hardtke MA, Sharpton TR, Rose B, Zlotnick A, Carr RI.
    Cancer; 1980 Feb 24; 45(3):460-8. PubMed ID: 6986198
    [No Abstract] [Full Text] [Related]

  • 34. Cutaneous delayed hypersensitivity responses to tumor-associated and other antigens in acute leukemia.
    Char DH, Lepourhiet BG, Herberman RB.
    Int J Cancer; 1973 Sep 15; 12(2):409-19. PubMed ID: 4524930
    [No Abstract] [Full Text] [Related]

  • 35. [Immunotherapy of cancer: evolution of concepts and clinical advances].
    Baldwin RW.
    Rev Prat; 1980 Jan 21; 30(5):221-4, 227-8. PubMed ID: 6929557
    [No Abstract] [Full Text] [Related]

  • 36. Mixed b.c.g. and irradiated-cell immunotherapy in acute leukemia.
    Zuhrie SR, Harris R, Geary C.
    Lancet; 1978 Jan 07; 1(8054):53. PubMed ID: 74538
    [No Abstract] [Full Text] [Related]

  • 37. Preliminary results of three protocols for the treatment of acute lymphoid leukaemia of children: distinction of two groups of patients according to predictable prognosis.
    Mathé G, De Vassal F, Schwarzenberg L, Delgado M, Weiner R, Gil MA, Pena-Angulo J, Belpomme D, Pouillart P, Machover D, Misset JL, Pico JL, Jasmin C, Hayat M, Schneider M, Cattan A, Amiel JL, Musset M, Rosenfeld C, Ribaud P.
    Med Pediatr Oncol; 1978 Jan 07; 4(1):17-27. PubMed ID: 272482
    [No Abstract] [Full Text] [Related]

  • 38. [Recent data on the immunotherapy of leukemias].
    Mathe G, Schwarzenberg L, Amiel JL, Pouillart P, Hayat M, De Vassal F, Rosenfeld C, Jasmin C.
    Recenti Prog Med; 1975 Oct 07; 59(4):314-29. PubMed ID: 769102
    [No Abstract] [Full Text] [Related]

  • 39. Phase II trial of active immunotherapy of acute myeloid leukemia.
    Mathé G, Musset M, Schwarzenberg L, Hayat M, de Vassal F, Amiel JL, Pouillart P, Misset JL.
    Biomedicine; 1975 Sep 10; 23(7):291-3. PubMed ID: 1066168
    [Abstract] [Full Text] [Related]

  • 40. [Immunological control over the action of BCG vaccine in the chemoimmunotherapy of acute leukemia in children].
    Kisliak NS, Averbakh MM, Bergolts VM, Moroz AM, Eremeev VS.
    Sov Med; 1978 Nov 10; (11):35-8. PubMed ID: 364684
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.